Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|May 21, 2014
Antischistosomal therapy: Current status and recent developmentsGamal Esmat, Maissa El Raziky
Cell Biochemistry and Biophysics|August 14, 2014
Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian studyOlfat Shaker, Amal Rashad, Ghada Abd El Aziz, et al.
Journal of Medical Virology|January 13, 2016
Seroprevalence of HCV among Cairo University students in EgyptGamal Esmat, Maissa El Raziky, Mohammed M Nabeel, et al.
Journal of Infection in Developing Countries|October 11, 2019
Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patientsAhmed Mohamed Kamel, Samar Farghali Farid, Ahmed Sherif Attia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continuesGamal Esmat, Mohamed El Kassas, Mohamed Hassany, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 6, 2025
Role of IL-6, TNF-α and VCAM-1 as predictors of renal impairment in patients with spontaneous bacterial peritonitisMaissa El Raziky, Mennatallah Rashwan, Hend Hamed Tamim, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 23, 2018
Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing RegimensMaissa El-Raziky, Marwa Khairy, Ahmed Fouad, et al.
Cell Biochemistry and Function|February 13, 2013
Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4Olfat Shaker, Amal El-Shehaby, Salwa Fayez, et al.
Journal of Medical Virology|May 9, 2017
ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis CMaissa El Raziky, Naglaa A Zayed, Amin Abdel Baki, et al.
Hepatitis Monthly|January 25, 2013
Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workupMarwa Khairy, Mahassen Abdel-Rahman, Maissa El-Raziky, et al.
Pageof 4